Larvol Delta - Ensovibep-a-SARSCoV2-antiviral-DARPin-is-safe-and-well-tolerated-in-healthy-volunteers-results-of-a-firstinhuman-ascending-singledose-Phase-1-study

ensovibep (MP0420) - AGC Biologics, Molecular Partners, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/37057679

Apr 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next